ID

23898

Beschreibung

Study part: Non- Serious Adverse Events. A phase 2 study to assess safety, reactogenicity and immunogenicity of a booster dose of an investigational vaccination regimen and GSK Biologicals Hib-MenC vaccine (co-administered with Infanrix penta) compared to a booster dose of Menjugate (co-administered with Infanrix hexa).Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Study ID: 100381, Clinical Study ID: 100381

Stichworte

Versionen (1)
  1. 17.07.17 17.07.17 -
Rechteinhaber

GlaxoSmithKline

Hochgeladen am

17. Juli 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Non- Serious Adverse Events Hib-MenCY-TT-004 BST 003 Neisseria Meningitidis-Haemophilus influenzae type b Vaccine 100381

Englisch

Non- Serious Adverse Events

1 Formulare  
NON-SERIOUS ADVERSE EVENTS
Beschreibung

NON-SERIOUS ADVERSE EVENTS

Alias
UMLS CUI-1
C1518404
Subject number
Beschreibung

Subject number

Datentyp

integer

Alias
UMLS CUI [1]
C2348585
Has any non-serious adverse events occurred within one month (minimum 30 days) post-vaccination, excluding those recorded on the Solicited Adverse Events pages?
Beschreibung

non-serious adverse events

Datentyp

boolean

Alias
UMLS CUI [1]
C1518404
Description
Beschreibung

Description Non- Serious Adverse Events

Datentyp

text

Alias
UMLS CUI [1,1]
C0678257
UMLS CUI [1,2]
C1518404
Administration sites
Beschreibung

site vaccines

Datentyp

integer

Alias
UMLS CUI [1,1]
C1515974
UMLS CUI [1,2]
C0042210
Non-administration site
Beschreibung

site vaccines

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1515974
UMLS CUI [1,2]
C0042210
Date Started
Beschreibung

Date Started

Datentyp

date

Alias
UMLS CUI [1]
C0808070
Date Started-during immediate post-vaccination period (at least 30 minutes)
Beschreibung

Date Started

Datentyp

boolean

Alias
UMLS CUI [1]
C0808070
Date Stopped
Beschreibung

Date Stopped

Datentyp

date

Alias
UMLS CUI [1]
C0806020
Intensity
Beschreibung

Intensity

Datentyp

text

Alias
UMLS CUI [1]
C1710066
Relationship to investigational products: Is there a reasonable possibility that the AE may have been caused by the investigational product?
Beschreibung

adverse event drug study

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0013227
UMLS CUI [1,3]
C0008972
Outcome
Beschreibung

Outcome

Datentyp

integer

Alias
UMLS CUI [1]
C1705586
Did the subject seek medical advice?
Beschreibung

medical advice

Datentyp

boolean

Alias
UMLS CUI [1]
C1386497
If yes please specify type:
Beschreibung

medical advice

Datentyp

integer

Alias
UMLS CUI [1]
C1386497
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Non- Serious Adverse Events

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
NON-SERIOUS ADVERSE EVENTS
C1518404 (UMLS CUI-1)
Subject number
Item
Subject number
integer
C2348585 (UMLS CUI [1])
non-serious adverse events
Item
Has any non-serious adverse events occurred within one month (minimum 30 days) post-vaccination, excluding those recorded on the Solicited Adverse Events pages?
boolean
C1518404 (UMLS CUI [1])
Description Non- Serious Adverse Events
Item
Description
text
C0678257 (UMLS CUI [1,1])
C1518404 (UMLS CUI [1,2])
Item
Administration sites
integer
C1515974 (UMLS CUI [1,1])
C0042210 (UMLS CUI [1,2])
site vaccines
Code List
Administration sites
CL Item
Hib-MenCY OR Hib-MenC vaccine [ 9 0 1 ] (1)
CL Item
MenC vaccine [ 9 0 2 ] (2)
CL Item
DTPa-HBV-IPV vaccine [ 1 4 ] (3)
CL Item
DTPa-HBV-IPV/Hib vaccine [ 3 8 ] (4)
site vaccines
Item
Non-administration site
boolean
C1515974 (UMLS CUI [1,1])
C0042210 (UMLS CUI [1,2])
Date Started
Item
Date Started
date
C0808070 (UMLS CUI [1])
Date Started
Item
Date Started-during immediate post-vaccination period (at least 30 minutes)
boolean
C0808070 (UMLS CUI [1])
Date Stopped
Item
Date Stopped
date
C0806020 (UMLS CUI [1])
Item
Intensity
text
C1710066 (UMLS CUI [1])
Intensity
Code List
Intensity
CL Item
Mild (Mild)
CL Item
Moderate (Moderate)
CL Item
Severe (Severe)
adverse event drug study
Item
Relationship to investigational products: Is there a reasonable possibility that the AE may have been caused by the investigational product?
boolean
C0877248 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0008972 (UMLS CUI [1,3])
Item
Outcome
integer
C1705586 (UMLS CUI [1])
Outcome
Code List
Outcome
CL Item
Recovered / Resolved (1)
CL Item
Recovering / resolving (2)
CL Item
Not recovered / not resolved (3)
CL Item
Recovered with sequelae /Resolved with sequelae (4)
medical advice
Item
Did the subject seek medical advice?
boolean
C1386497 (UMLS CUI [1])
Item
If yes please specify type:
integer
C1386497 (UMLS CUI [1])
medical advice
Code List
If yes please specify type:
CL Item
HO: Hospitalisation (1)
CL Item
ER: Emergency room (2)
CL Item
MD: Medical doctor (3)
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video